Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.Donate to our crowdfunder
The Department welcomes the recent research on the potential use of Bdellovibrio bacteriovorus in destroying antibiotic resistant bacteria, since such novel therapies may help to slow the development and spread of antimicrobial resistance.
The research demonstrates an unusual approach to tackling resistant bacteria, but it is too soon to assess the efficacy of this method in human therapeutic use, as it is still at an early stage. Nevertheless, it does offer a new potential mechanism for combatting resistant infections, which would be valuable given the lack of new antibiotics. Depending on how the research progresses, we will consult with our expert advisory scientific committee to assess the application of such research for human therapeutic use.